Literature DB >> 18251781

Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006.

Ryosuke Aoki1, Kennosuke Karube, Yasuo Sugita, Yuko Nomura, Kay Shimizu, Yoshizo Kimura, Keiko Hashikawa, Nobuko Suefuji, Masahiro Kikuchi, Koichi Ohshima.   

Abstract

The World Health Organization classification was used to conduct an analysis of geographic, age, sex, and lesion primarily biopsied/resected distribution of 2260 lymphoid neoplasms diagnosed during 2001-2006 throughout Japan. B-cell neoplasms accounted for 65% of all lymphoid neoplasms, T/natural killer (T/NK)-cell neoplasms for 25% and Hodgkin lymphoma for 7%. The most common type was diffuse large B-cell lymphoma (DLBCL, 33%), followed by follicular lymphoma (18%), and adult T-cell leukemia/lymphoma (ATLL, 10%). The high rate of 18% for follicular lymphoma was similar to that in Western countries (11-33%). T/NK-cell neoplasms accounted for a higher percentage of lymphoid neoplasms in Kyushu (30%) and Okinawa (38%) compared with other areas of Japan (18-20%). Among T/NK-cell neoplasms, ATLL was the most common type in Okinawa (54%) and Kyushu (59%). Extranodal NK/T cell lymphoma was the second most common type of T/NK-cell neoplasms in Okinawa (15%). This epidemiological study shows that the distribution patterns of malignant lymphoma differ especially in Kyushu and Okinawa, the endemic area of human T-cell leukemia/lymphoma virus type 1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18251781     DOI: 10.1111/j.1440-1827.2007.02207.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  40 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

Review 2.  New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.

Authors:  Lester D R Thompson; Alessandro Franchi
Journal:  Virchows Arch       Date:  2017-04-25       Impact factor: 4.064

3.  High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma.

Authors:  Kwonoh Park; Dok Hyun Yoon; Shin Kim; Chan-Sik Park; Jooryung Huh; Sang-Wook Lee; Cheolwon Suh
Journal:  Int J Hematol       Date:  2013-01-26       Impact factor: 2.490

Review 4.  Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

5.  Current status and progress of lymphoma research in East Asian countries: Introduction and planning.

Authors:  Junji Suzumiya
Journal:  Int J Hematol       Date:  2018-02-28       Impact factor: 2.490

Review 6.  Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia/lymphoma in Japan.

Authors:  Hiroaki Miyoshi; Koichi Ohshima
Journal:  Int J Hematol       Date:  2018-03-03       Impact factor: 2.490

7.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.

Authors:  Noah A Brown; Kojo S J Elenitoba-Johnson
Journal:  Head Neck Pathol       Date:  2017-02-28

8.  Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016.

Authors:  Akiko Miyagi Maeshima; Hirokazu Taniguchi; Tomotaka Suzuki; Sayako Yuda; Kosuke Toyoda; Nobuhiko Yamauchi; Shinichi Makita; Suguru Fukuhara; Wataru Munakata; Dai Maruyama; Yukio Kobayashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2017-09-18       Impact factor: 2.490

Review 9.  Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature.

Authors:  Brady E Beltran; Pilar Quiñones; Domingo Morales; Jose C Alva; Roberto N Miranda; Gary Lu; Bijal D Shah; Eduardo M Sotomayor; Jorge J Castillo
Journal:  Leuk Res       Date:  2013-06-20       Impact factor: 3.156

10.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.

Authors:  J Han J M van Krieken
Journal:  J Hematop       Date:  2008-07       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.